# FDA 483 - Dee Cee Laboratories, Inc - August 11, 2025

Source: https://www.keypedia.com/records/483/dee-cee-laboratories-inc/61f9c7ac-5466-4c62-9377-9c6f8b73af52

> FDA 483 for Dee Cee Laboratories, Inc on August 11, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Dee Cee Laboratories, Inc
- Inspection Date: 2025-08-11
- Product Type: drugs
- Office Name: New Orleans District Office
- Summary: Dee Cee Laboratories, Inc. in White House, TN, was inspected and received a Form 483 with seven observations related to significant deficiencies in their quality control unit, manufacturing process validation, cleaning procedures, stability assessment, equipment qualification, annual product review, and in-process controls. The firm manufactures homeopathic drug products and demonstrated a lack of control over critical processes and documentation. These issues indicate a systemic failure to adhere to good manufacturing practices.

## Related Officers

- [Tomika L. Crafter](https://www.keypedia.com/people/tomika-l-crafter/6c8260a0-c026-496d-80f6-9c30877e8f52)
- [company_representative](https://www.keypedia.com/people/nelson-n-ayangho/917cb8ea-904d-41a1-b522-2351d3cb1f74)
- [issuing_officer](https://www.keypedia.com/people/inga-m-warr/f27805b8-c2ba-4af5-bf5e-ff2e2f511ec1)

Company: https://www.keypedia.com/companies/dee-cee-laboratories-inc/f548e581-27ab-491d-a3b5-47c1e072d498

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea